Liver Disease
Resource Center
Featured
06/29/2022
To better understand mortality trends within the United States, researchers examined the rate of death in people who died of alcohol-related liver disease.
06/29/2022
04/01/2022
A 10-year-old boy with no significant medical history presented for evaluation after an unwitnessed fall forward from rollerblades onto asphalt. The patient reported no loss of consciousness after the fall...
04/01/2022
12/22/2021
A 60-year-old man with no significant medical history presented to the emergency department (ED) with a 5-week history of fevers and chills associated with night sweats, decreased appetite, and a 0.9-kg...
12/22/2021
Interactive Features
11/12/2020
Individuals with NASH and significant liver fibrosis have a higher risk for serious liver-related outcomes compared with those with simple steatosis. Which endpoint should be a target for treatment: NASH...
11/12/2020
06/30/2020
Do you know the percentage of patients with nonalcoholic fatty liver disease who will develop progressive disease? Test your knowledge with our pop quiz!
06/30/2020
06/30/2020
The gut microbiome affects the development and progression of nonalcoholic fatty liver disease. Do you know which part of the hepatic portal system connects the liver with the intestine?
06/30/2020
12/13/2018
Can regular aspirin use reduce liver cancer risk?
12/13/2018
08/14/2018
A diet heavy in what type of food could lead to an increased risk of non-alcoholic fatty liver disease?
08/14/2018
Clinical Insights
11/22/2021
In this short video, Jordan Feld, MD, MPH, talks about his team's latest research on hepatitis C virus infections among patients taking pre-exposure prophylaxis for HIV infection.
11/22/2021
11/04/2020
In this video, James Matera, DO, gives a preview of his presentation on the differences between NASH and NAFLD, which will be presented at the Practical Updates in Primary Care 2020 Virtual Series on...
11/04/2020
09/29/2020
He talks about how and why metabolic pathways are targeted when treating nonalcoholic fatty liver disease. He recently spoke about this topic at the 21st Annual Harvard Nutrition and Obesity Symposium on...
09/29/2020
08/28/2020
He talks about how to make progress in the treatment of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. He recently spoke about this topic at the 21st Annual Harvard Nutrition and Obesity...
08/28/2020
02/20/2020
In this podcast, Marc Ghany, MD, MHSc, discusses the recent publication of "Hepatitis C Guidance 2019 Update: AASLD‐IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection." He...
02/20/2020
